[go: up one dir, main page]

DK2961766T3 - Kvantificering af vaccinesammensætninger - Google Patents

Kvantificering af vaccinesammensætninger Download PDF

Info

Publication number
DK2961766T3
DK2961766T3 DK14711887.1T DK14711887T DK2961766T3 DK 2961766 T3 DK2961766 T3 DK 2961766T3 DK 14711887 T DK14711887 T DK 14711887T DK 2961766 T3 DK2961766 T3 DK 2961766T3
Authority
DK
Denmark
Prior art keywords
quantification
vaccine compositions
vaccine
compositions
Prior art date
Application number
DK14711887.1T
Other languages
English (en)
Inventor
Marc Allan Eichmeyer
Michael B Roof
Merrill Lynn Schaeffer
Eric Martin Vaughn
Kun Yang
Jeremy Richard Rush
Daniel John Murfin
Original Assignee
Boehringer Ingelheim Animal Health Usa Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Animal Health Usa Inc filed Critical Boehringer Ingelheim Animal Health Usa Inc
Application granted granted Critical
Publication of DK2961766T3 publication Critical patent/DK2961766T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848Methods of protein analysis involving mass spectrometry
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK14711887.1T 2013-03-01 2014-02-28 Kvantificering af vaccinesammensætninger DK2961766T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361771226P 2013-03-01 2013-03-01
PCT/US2014/019643 WO2014134561A2 (en) 2013-03-01 2014-02-28 Quantification of vaccine compositions

Publications (1)

Publication Number Publication Date
DK2961766T3 true DK2961766T3 (da) 2019-07-15

Family

ID=50343846

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14711887.1T DK2961766T3 (da) 2013-03-01 2014-02-28 Kvantificering af vaccinesammensætninger

Country Status (6)

Country Link
US (2) US9624527B2 (da)
EP (2) EP3587439A3 (da)
CN (1) CN105026419B (da)
DK (1) DK2961766T3 (da)
ES (1) ES2734374T3 (da)
WO (1) WO2014134561A2 (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA95602C2 (ru) 2004-12-30 2011-08-25 Берингер Ингельхейм Ветмедика, Инк. Иммуногенная композиция цвс2 и способы приготовления такой композиции
EP3320919B1 (en) 2005-12-29 2020-05-27 Boehringer Ingelheim Animal Health USA Inc. Multivalent pcv2 immunogenic compositions and methods of producing such compositions
DK2371383T3 (da) 2005-12-29 2015-11-30 Boehringer Ingelheim Vetmed Anvendelse af en PCV2-immunogen sammensætning til mindskning af kliniske symptomer i grise
EP2859900A1 (en) 2006-12-11 2015-04-15 Boehringer Ingelheim Vetmedica, Inc. Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
EP1941903A1 (en) 2007-01-03 2008-07-09 Boehringer Ingelheim Vetmedica Gmbh Prophylaxis and treatment of PRDC
EP1958644A1 (en) 2007-02-13 2008-08-20 Boehringer Ingelheim Vetmedica Gmbh Prevention and treatment of sub-clinical pcvd
US7829274B2 (en) 2007-09-04 2010-11-09 Boehringer Ingelheim Vetmedica, Inc. Reduction of concomitant infections in pigs by the use of PCV2 antigen
CA2712006A1 (en) 2008-01-23 2009-10-15 Boehringer Ingelheim Vetmedica, Inc. Pcv2 mycoplasma hyopneumoniae immunogenic compositions and methods of producing such compositions
EP3587439A3 (en) 2013-03-01 2020-03-11 Boehringer Ingelheim Animal Health USA Inc. Improved quantification of vaccine compositions
KR20220083861A (ko) * 2013-10-02 2022-06-20 베링거 인겔하임 애니멀 헬스 유에스에이 인크. Pcv2 orf2 단백질 변이체 및 이로 이루어진 바이러스 유사 입자
ES2836432T3 (es) * 2015-03-18 2021-06-25 Janssen Vaccines & Prevention Bv Ensayos para sistemas de expresión recombinante
EP3287788B1 (en) * 2016-08-22 2018-11-14 BiognoSYS AG Methods for mass spectrometry-based quantification using labelled compounds
CN107056897B (zh) * 2017-01-22 2020-08-25 中牧实业股份有限公司 猪圆环合成肽疫苗及其制备方法和应用
CN106980021B (zh) * 2017-03-31 2018-10-26 李森康 一种能够验证酶解效果的基于酶解多肽原理的蛋白质检测技术
ES2962449T3 (es) 2017-10-17 2024-03-19 Intervet Int Bv Expresión recombinante de la proteína ORF2 del PCV2b en células de insecto
US12292448B2 (en) 2018-05-24 2025-05-06 Sigma-Aldrich Co. Llc Quantitative analysis of proteins
WO2019232520A1 (en) 2018-06-01 2019-12-05 Cerno Bioscience Llc Mass spectral analysis of large molecules
CN109678933B (zh) * 2019-02-27 2021-11-26 河南省农业科学院 针对猪圆环病毒2型Cap蛋白的高亲和性多肽序列及其应用
TWI758988B (zh) 2020-12-03 2022-03-21 國立成功大學 定量測量血液樣品中兒茶酚雌激素結合的蛋白之方法
CN115326937B (zh) * 2021-05-11 2024-06-18 山东省食品药品检验研究院 一种基因毒杂质捕捉用固相探针及其使用方法与应用
CN115201368A (zh) * 2022-07-11 2022-10-18 常州市中医医院 一种猪心血和猪血质量控制方法
WO2025129040A1 (en) * 2023-12-13 2025-06-19 Vetanco Usa Inc. Porcine circovirus type 2 (pcv2) immunogenic compositions and methods of stimulating an immune response to pcv2

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2909462A (en) 1955-12-08 1959-10-20 Bristol Myers Co Acrylic acid polymer laxative compositions
US4440859A (en) 1977-05-27 1984-04-03 The Regents Of The University Of California Method for producing recombinant bacterial plasmids containing the coding sequences of higher organisms
US4704362A (en) 1977-11-08 1987-11-03 Genentech, Inc. Recombinant cloning vehicle microbial polypeptide expression
IN151589B (da) 1978-12-22 1983-05-28 Biogen Nv
US4530901A (en) 1980-01-08 1985-07-23 Biogen N.V. Recombinant DNA molecules and their use in producing human interferon-like polypeptides
US4678751A (en) 1981-09-25 1987-07-07 Genentech, Inc. Hybrid human leukocyte interferons
US4766075A (en) 1982-07-14 1988-08-23 Genentech, Inc. Human tissue plasminogen activator
US4582800A (en) 1982-07-12 1986-04-15 Hoffmann-La Roche Inc. Novel vectors and method for controlling interferon expression
US4757006A (en) 1983-10-28 1988-07-12 Genetics Institute, Inc. Human factor VIII:C gene and recombinant methods for production
US4677063A (en) 1985-05-02 1987-06-30 Cetus Corporation Human tumor necrosis factor
US4810648A (en) 1986-01-08 1989-03-07 Rhone Poulenc Agrochimie Haloarylnitrile degrading gene, its use, and cells containing the gene
EP0934410A1 (en) 1996-10-11 1999-08-11 Human Genome Sciences, Inc. Brain-associated inhibitor of tissue-type plasminogen activator
FR2772047B1 (fr) 1997-12-05 2004-04-09 Ct Nat D Etudes Veterinaires E Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
DE60239962D1 (de) * 2001-08-14 2011-06-16 Harvard College Absolute quantifizierung von proteinen und modifizierten formen davon mittels mehrstufiger massenspektrometrie
DE102004031282A1 (de) 2004-06-29 2006-01-26 Thyssenkrupp Automotive Ag Verfahren zum Befestigen von Fixierringen auf Stabilisatoren für Kraftfahrzeuge
SI1833992T1 (sl) * 2004-12-30 2015-06-30 Boehringer Ingelheim Vetmedica, Inc. PCV2 imunogeni sestavki in postopki proizvodnje takšnih sestavkov
US7833707B2 (en) 2004-12-30 2010-11-16 Boehringer Ingelheim Vetmedica, Inc. Methods of overexpression and recovery of porcine circovirus type 2 ORF2
EP3320919B1 (en) 2005-12-29 2020-05-27 Boehringer Ingelheim Animal Health USA Inc. Multivalent pcv2 immunogenic compositions and methods of producing such compositions
EP1941903A1 (en) 2007-01-03 2008-07-09 Boehringer Ingelheim Vetmedica Gmbh Prophylaxis and treatment of PRDC
WO2008146100A1 (en) * 2007-06-01 2008-12-04 INSERM (Institut National de la Santé et de la Recherche Médicale) Method for absolute quantification of polypeptides
TWI401319B (zh) * 2008-03-28 2013-07-11 Nat Univ Chung Hsing 豬環狀病毒二型外殼蛋白次單位片段及其用途
EP3587439A3 (en) * 2013-03-01 2020-03-11 Boehringer Ingelheim Animal Health USA Inc. Improved quantification of vaccine compositions

Also Published As

Publication number Publication date
EP2961766B1 (en) 2019-04-10
CN105026419A (zh) 2015-11-04
EP3587439A2 (en) 2020-01-01
CN105026419B (zh) 2021-08-24
EP3587439A3 (en) 2020-03-11
US20140248603A1 (en) 2014-09-04
EP2961766A2 (en) 2016-01-06
US20170253908A1 (en) 2017-09-07
WO2014134561A2 (en) 2014-09-04
US9624527B2 (en) 2017-04-18
ES2734374T3 (es) 2019-12-05
WO2014134561A3 (en) 2014-10-23
US10767213B2 (en) 2020-09-08

Similar Documents

Publication Publication Date Title
IL282401A (en) Complement component irna compositions and methods of use thereof
DK2961766T3 (da) Kvantificering af vaccinesammensætninger
IL269227B (en) Solid forms of treprostinil
DK2845905T3 (da) Fremstilling af oligosaccharider
DK3080100T3 (da) Hæmmere af lysinspecifik demethylase-1
DK2968208T3 (da) Behandling af kataplexi
DK2981255T3 (da) Terapeutiske anvendelser af empagliflozin
DK2984166T3 (da) Sammensætninger til behandling af mpsi
DK3456831T3 (da) Målrettet modifikation af rottegenom
DK2968529T3 (da) Fremstilling af jordnøddeformuleringer til oral desensibilisering
DK3611262T3 (da) Fremgangsmåder til sekvensering af immunrepertoire
DK2970954T3 (da) Modifikation af polypeptider
DK2968221T3 (da) Farmaceutisk sammensætning af s-ketaminhydrochlorid
DK2961388T3 (da) Kombinationer af lægemidler
DK3027618T3 (da) Polymorf af syk-hæmmere
EP2979681A4 (en) HARDENING COMPOSITION
DK3079669T3 (da) Sammensætninger med forsinket frigivelse af linaclotid
DK3106150T3 (da) Forbedrede farmaceutiske sammensætninger af pimobendan
EP2958994A4 (en) Vaccine composition
DK3042540T3 (da) Elektrotermske sammensætninger
PT2953948T (pt) Antagonistas de integrina fluorada
DK3027750T3 (da) Biokatalytisk sammensætning
PT3071638T (pt) Composição de cianoacrilato
DK2965026T3 (da) Generering af slushice
DK2822568T3 (da) Anvendelser af caseinsammensætninger